CYP3A4 expression to predict treatment response to docetaxel for metastasis and recurrence of primary breast cancer (Q84010791)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533940%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

CYP3A4 expression to predict treatment response to docetaxel for metastasis and recurrence of primary breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533940%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

Kenichi Sakurai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533940%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Katsuhisa Enomoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533940%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Sadanori Matsuo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533940%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Sadao Amano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533940%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Motomi Shiono

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533940%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533940%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533940%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533940%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533940%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

674-679

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533940%20AND%20SRC:MED&resulttype=core&format=json

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

30 January 2020

cites work

1 reference

12 December 2020

MGMT- and P450 3A-inhibitors do not sensitize glioblastoma cell cultures against nitrosoureas

1 reference

12 December 2020

Intestinal expression of cytochrome P450 enzymes and ABC transporters and carbamazepine and phenytoin disposition

1 reference

12 December 2020

An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer

1 reference

12 December 2020

RPN2 gene confers docetaxel resistance in breast cancer

1 reference

12 December 2020

A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group.

1 reference

12 December 2020

Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues

1 reference

12 December 2020

Expression of cytochrome P450 3A4 and its clinical significance in human prostate cancer.

1 reference

12 December 2020

Prediction of response to docetaxel by immunohistochemical analysis of CYP3A4 expression in human breast cancers

1 reference

12 December 2020

The role of beta-tubulin isotypes in resistance to antimitotic drugs

1 reference

12 December 2020

P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR.

1 reference

12 December 2020

Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer

1 reference

12 December 2020

Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer

1 reference

12 December 2020

Docetaxel (Taxotere) for the treatment of anthracycline-resistant breast cancer

1 reference

12 December 2020

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

12 December 2020

Pharmacogenetics in breast cancer therapy

1 reference

12 December 2020

Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers.

1 reference

12 December 2020

Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.

1 reference

12 December 2020

Expression of CYP3A4 in human breast tumour and non-tumour tissues

1 reference

12 December 2020

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

12 December 2020

High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients

1 reference

12 December 2020

An overview of phase II studies of docetaxel in patients with metastatic breast cancer

1 reference

12 December 2020

Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen

1 reference

12 December 2020

Expression of cytochromes P450 in human breast tissue and tumors

1 reference

12 December 2020

Induction of cytochrome P450 3A4 by docetaxel in peripheral mononuclear cells and its expression in lung cancer

1 reference

12 December 2020

Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial

1 reference

12 December 2020

Prediction of response to docetaxel by quantitative analysis of class I and III beta-tubulin isotype mRNA expression in human breast cancers.

1 reference

12 December 2020

Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR).

1 reference

12 December 2020

10.1007/S00595-009-4328-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533940%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference